Target intelligence / Profile preview

Adenylate kinase 2 pseudogene 2 (AK2P2)

Target: AK2P2
Molecular classification: Pseudogene

Overview

Adenylate kinase 2 pseudogene 2 (AK2P2) is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically result from gene duplication or retrotransposition and lack the capability to encode a functional protein. AK2P2 is a non-coding sequence related to the functional Adenylate kinase 2 (AK2), which is involved in phosphate transfer and cellular energy homeostasis. Unlike AK2, AK2P2 does not code for a protein and has no reported biological, pharmacological, or disease roles[4]. No drugs are known to interact with this pseudogene, and it is not considered a therapeutic target.

Other names: Adenylate kinase 2 pseudogene 2AK2P2

Beyond the preview

Go deeper on Adenylate kinase 2 pseudogene 2 (AK2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenylate kinase 2 pseudogene 2 (AK2P2).

Explore the full profile